Adenocarcinoma of the lung screening: Difference between revisions

Jump to navigation Jump to search
(Redirected page to Lung cancer screening)
No edit summary
 
(9 intermediate revisions by 2 users not shown)
Line 1: Line 1:
#REDIRECT[[Lung cancer screening]]
__NOTOC__
{{Adenocarcinoma of the lung}}
{{CMG}}; {{AE}} {{SC}}
 
==Overview==
According to the [[United states preventive services task force recommendations scheme|U.S. Preventive Services Task Force]] ([[USPSTF]]), screening for [[lung cancer]] by [[Computed tomography|low-dose computed tomography (LDCT)]] is recommended every year among smokers and former smokers who are between 55 to 80 years old and who have smoked 30 pack-years or more and either continue to smoke or have quit within the past 15 years (grade B recommendation). According to the [[clinical practice guideline]] issued by the [[American College of Chest Physicians]] (CHEST) in 2013, screening for [[lung cancer]] by [[CT|low-dose CT (LDCT)]] is recommended every year among smokers and former smokers who are age 55 to 74 and who have smoked for 30 pack-years or more and either continue to smoke or have quit within the past 15 years.
 
==Screening==
'''Guidelines'''
* According to the [[United states preventive services task force recommendations scheme|U.S. Preventive Services Task Force]] ([[USPSTF]]), screening for [[lung cancer]] by [[Computed tomography|low-dose computed tomography (LDCT)]] is recommended every year among smokers and former smokers who are between 55 to 80 years old and who have smoked 30 pack-years or more and either continue to smoke or have quit within the past 15 years (grade B recommendation).<ref name="abc">Lung Cancer Screening. U.S. Preventive Services Task Force 2015. http://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/lung-cancer-screening Accessed on December 20, 2015</ref>
 
* According to the [[American College of Chest Physicians]] (CHEST) in 2013, screening for [[lung cancer]] by [[CT|low-dose CT (LDCT)]] is recommended every year among smokers and former smokers who are age 55 to 74 and who have smoked for 30 pack-years or more and either continue to smoke or have quit within the past 15 years.<ref name="pmid23649455">{{cite journal| author=Detterbeck FC, Mazzone PJ, Naidich DP, Bach PB| title=Screening for Lung Cancer: Diagnosis and Management of Lung Cancer, 3rd ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. | journal=Chest | year= 2013 | volume= 143 | issue= 5 Suppl | pages= e78S-92S | pmid=23649455 | doi=10.1378/chest.12-2350 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=23649455  }} [http://general-medicine.jwatch.org/cgi/content/full/2013/522/2 Summary in JournalWatch]</ref>
 
'''Strategies'''<ref>Lung Cancer Screening. National Cancer Institute 2015. http://www.cancer.gov/types/lung/hp/lung-screening-pdq Accessed on December 20, 2015</ref>
* [[Computed tomography|Low-dose helical computed tomography]]:
:* Advantages:
::* There is evidence that screening 55 to 74 year old smokers of 30 or more pack-years or former smokers, who have quit within the last 15 years, reduces lung cancer [[Mortality rate|mortality]] by 20% and [[Mortality|all-cause mortality]] by 6.7%.
 
:* Diasdvantages:
::* At least 98% of all positive low-dose helical [[computed tomography]] screening exams do not result in a [[lung cancer]] diagnosis.
::* [[False-positive|False-positive exams]] may result in unnecessary invasive diagnostic procedures.
 
* [[Chest X-ray|Chest x-ray]] and/or [[Sputum|sputum cytology]]:
:* Advantages:
::* Screening with [[Chest X-ray|chest x-ray]] and/or [[Cytology|sputum cytology]] has no role in reducing [[Mortality rate|mortality]] from lung cancer in the general population.
 
:* Disadvantages:
::* [[False positive]] exams
::* At least 95% of all positive [[Chest X-ray|chest x-ray]] screening exams do not result in a [[lung cancer]] diagnosis.
::* [[False-positive]] exams result in unnecessary invasive diagnostic procedures.
 
==References==
{{reflist|2}}
 
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
 
[[Category:Disease]]
[[Category:Types of cancer]]
[[Category:Pulmonology]]
[[Category:Lung cancer]]
[[Category:Oncology]]

Latest revision as of 14:55, 6 March 2018

Adenocarcinoma of the Lung Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Adenocarcinoma of the Lung from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

Echocardiography and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Intervention

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Adenocarcinoma of the lung screening On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Adenocarcinoma of the lung screening

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Adenocarcinoma of the lung screening

CDC on Adenocarcinoma of the lung screening

Adenocarcinoma of the lung screening in the news

Blogs on Adenocarcinoma of the lung screening

Directions to Hospitals Treating Adenocarcinoma of the lung

Risk calculators and risk factors for Adenocarcinoma of the lung screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shanshan Cen, M.D. [2]

Overview

According to the U.S. Preventive Services Task Force (USPSTF), screening for lung cancer by low-dose computed tomography (LDCT) is recommended every year among smokers and former smokers who are between 55 to 80 years old and who have smoked 30 pack-years or more and either continue to smoke or have quit within the past 15 years (grade B recommendation). According to the clinical practice guideline issued by the American College of Chest Physicians (CHEST) in 2013, screening for lung cancer by low-dose CT (LDCT) is recommended every year among smokers and former smokers who are age 55 to 74 and who have smoked for 30 pack-years or more and either continue to smoke or have quit within the past 15 years.

Screening

Guidelines

Strategies[3]

  • Advantages:
  • There is evidence that screening 55 to 74 year old smokers of 30 or more pack-years or former smokers, who have quit within the last 15 years, reduces lung cancer mortality by 20% and all-cause mortality by 6.7%.
  • Diasdvantages:
  • Advantages:
  • Disadvantages:

References

  1. Lung Cancer Screening. U.S. Preventive Services Task Force 2015. http://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/lung-cancer-screening Accessed on December 20, 2015
  2. Detterbeck FC, Mazzone PJ, Naidich DP, Bach PB (2013). "Screening for Lung Cancer: Diagnosis and Management of Lung Cancer, 3rd ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines". Chest. 143 (5 Suppl): e78S–92S. doi:10.1378/chest.12-2350. PMID 23649455. Summary in JournalWatch
  3. Lung Cancer Screening. National Cancer Institute 2015. http://www.cancer.gov/types/lung/hp/lung-screening-pdq Accessed on December 20, 2015


Template:WikiDoc Sources